HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gd-EOB-DTPA enhancement pattern of hepatocellular carcinomas in rats: comparison with Tc-99m-IDA uptake.

Abstract
The enhancement pattern of chemically induced hepatocellular carcinomas (HCCs) after intravenous administration of the hepatobiliary magnetic resonance (MR) contrast agent gadolinium-EOB-DTPA (ethoxybenzyl-diethylenetriaminepentaacetic acid) was compared with the uptake pattern of technetium-99m-labeled iminodiacetic acid (IDA), a hepatobiliary radioactive tracer. The hepatocyte uptake of both the contrast agent and the scintigraphic agent has been shown to be driven by the organic anion transporter. The tumors enhanced less than the liver after Gd-EOB-DTPA administration, whereas the Tc-99m-IDA uptake of differentiated HCCs exceeded that of the liver at 30 minutes and 3 hours after administration. The enhancement pattern of a differentiated HCC with Gd-EOB-DTPA does not mirror that seen with Tc-99m-IDA.
AuthorsB E Van Beers, C Grandin, S Pauwels, I Mottet, J F Goudemant, M Delos, R Demeure, J Pringot
JournalJournal of magnetic resonance imaging : JMRI (J Magn Reson Imaging) 1994 May-Jun Vol. 4 Issue 3 Pg. 351-4 ISSN: 1053-1807 [Print] United States
PMID8061433 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Imino Acids
  • Organometallic Compounds
  • Organotechnetium Compounds
  • gadolinium ethoxybenzyl DTPA
  • technetium Tc 99m iminodiacetic acid
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA
Topics
  • Animals
  • Contrast Media
  • Gadolinium
  • Gadolinium DTPA
  • Imino Acids
  • Liver (diagnostic imaging, pathology)
  • Liver Neoplasms, Experimental (diagnosis, diagnostic imaging)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Organometallic Compounds
  • Organotechnetium Compounds
  • Pentetic Acid (analogs & derivatives)
  • Radionuclide Imaging
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: